NCT02709889 2020-10-19Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid TumorsAbbViePhase 1/2 Terminated200 enrolled 21 charts
NCT00629473 2017-11-22Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced MalignanciesCelgenePhase 1 Completed86 enrolled